Liposomal irinotecan+5-fluorouracil/leucovorin plus oxaliplatin as a first line treatment for the management of metastatic pancreatic adenocarcinoma: A budget impact analysis from a US payer perspective

被引：0
|
作者：
Kim, George P.
Holland, Theo
Patrick, Caity
Lewis, Megan
Cockrum, Paul
Eddy, Alexandra
机构：
[1] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
[2] FIECON, London, England
[3] Ipsen, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16339
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [22] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [23] First-line liposomal irinotecan+5 fluorouracil/leucovorin plus oxaliplatin in patients with pancreatic ductal adenocarcinoma: Long-term follow-up results from a phase 1/2 study
    Wainberg, Z.
    Bekaii-Saab, T.
    Boland, P.
    Dayyani, F.
    Macarulla, T.
    Mody, K.
    Belanger, B.
    Maxwell, F.
    Moore, Y.
    Thiagalingam, A.
    Wang, T.
    Zhang, B.
    Dean, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S241 - S241
  • [24] BUDGET IMPACT ANALYSIS OF NANOLIPOSOMAL IRINOTECAN FOR TREATMENT OF PANCREATIC CANCER FOLLOWING PROGRESSION ON GEMCITABINE - A US PAYER PERSPECTIVE
    Becker, C.
    Mamlouk, K.
    Li, H.
    VALUE IN HEALTH, 2016, 19 (07) : A718 - A719
  • [25] Liposomal irinotecan+5-fluorouracil/leucovorin plus oxaliplatin (NALIRIFOX) versus nab-paclitaxel plus gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): 12-and 18-month survival rates from the phase 3 NAPOLI 3 trial
    O'Reilly, Eileen Mary
    Melisi, Davide
    Macarulla, Teresa
    Roberto, A.
    Cid, Pazo
    Chandana, Sreenivasa R.
    De La Fouchardiere, Christelle
    Dean, Andrew Peter
    Kiss, Igor
    Lee, Woo Jin
    Goetze, Thorsten Oliver
    Van Cutsem, Eric
    Paulson, Scott
    Bekaii-Saab, Tanios S.
    Pant, Shubham
    Hubner, Richard
    Xiao, Zhimin
    Chen, Huanyu
    Benzaghou, Fawzi
    Wainberg, Zev A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
    Chiu, Tai-Jan
    Yang, Shih-Hung
    Chiu, Sz-Chi
    Hsueh, Shun-Wen
    Chiang, Nai-Jung
    Li, Chung-Pin
    Bai, Li-Yuan
    Cheng, Fu-Ming
    Chuang, Shih-Chang
    Shan, Yan-Shen
    Chan, De-Chuan
    Chen, Li-Tzong
    Yen, Chia-Jui
    Peng, Cheng-Ming
    Su, Yung-Yeh
    Chen, Yen-Yang
    Chen, Jen-Shi
    Chou, Wen-Chi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2022, 29 (06) : 670 - 681
  • [27] 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer
    Grande, C.
    Martinez, M.
    Villanueva, M. J.
    Huidobro, G.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S469 - S469
  • [28] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [29] The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma A Single-Center Real-World Study
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Chiu, Jing-Huey
    Ma, Kevin Sheng-Kai
    Chen, Brian Shiian
    Luan, Yu-Ze
    Cheng, Teng-Chieh
    Hsieh, Ching-Lung
    Peng, Cheng-Ming
    PANCREAS, 2022, 51 (08) : E107 - E109
  • [30] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
12345